| Correlates of adjuvanticity: A review on adjuvants in licensed vaccines |
81 |
| Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells |
43 |
| Non-specific effects of vaccines: Current evidence and potential implications |
43 |
| High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells |
40 |
| The integration of inflammaging in age-related diseases |
39 |
| Vaccination in the elderly: The challenge of immune changes with aging |
38 |
| Immunologic mechanisms in asthma |
37 |
| Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment |
33 |
| NLRP3 inflammasome activation in inflammaging |
31 |
| Global virus outbreaks: Interferons as 1st responders |
29 |
| Antibody glycosylation in inflammation, disease and vaccination |
22 |
| Dendritic cells in the regulation of immunity and inflammation |
20 |
| Tim-3: A co-receptor with diverse roles in T cell exhaustion and tolerance |
19 |
| The intestinal complement system in inflammatory bowel disease: Shaping intestinal barrier function |
17 |
| Complement dysregulation in the central nervous system during development and disease |
16 |
| Immune regulation by monocytes |
16 |
| Mast cells, basophils and eosinophils: From allergy to cancer |
15 |
| The dark side of tumor-associated endothelial cells |
15 |
| Human genetics of infectious diseases: Unique insights into immunological redundancy |
15 |
| Aging, inflammation and cancer |
15 |
| Targeting the adenosine pathway for cancer immunotherapy |
14 |
| NK cells to cure cancer |
14 |
| A short field guide to fibroblast function in immunity |
13 |
| VISTA: A novel immunotherapy target for normalizing innate and adaptive immunity |
13 |
| Severe asthma phenotypes and endotypes |
12 |
| The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin |
12 |
| Innate lymphoid cells in intestinal cancer development |
11 |
| Mesenchymal-myeloid interaction in the regulation of immunity |
11 |
| Regulation of regulators: Role of the complement factor H-related proteins |
11 |
| Targeting complement-mediated immunoregulation for cancer immunotherapy |
11 |
| Complement involvement in bone homeostasis and bone disorders |
11 |
| Immunocorrelates of CAF family adjuvants |
10 |
| Correlates of immune and clinical activity of novel cancer vaccines |
10 |
| Insights into the role of IL-32 in cancer |
10 |
| Chemokines sound the alarmin: The role of atypical chemokine in inflammation and cancer |
10 |
| Il-10 producing T and B cells in allergy |
10 |
| Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor |
9 |
| Changes in the biochemical taste of cytoplasmic and cell-free DNA are major fuels for inflamm-aging |
9 |
| Immune induction of airway remodeling |
9 |
| An unexpected player in Gaucher disease: The multiple roles of complement in disease development |
8 |
| IFN-gamma: A cytokine at the right time, is in the right place |
8 |
| The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p HABP-1)(1) |
8 |
| Functions and regulation of T cell-derived interleukin-10 |
8 |
| Epigenetic and transcriptional mechanisms for the regulation of IL-10 |
8 |
| IL-10-producing regulatory B cells and plasmocytes: Molecular mechanisms and disease relevance |
8 |
| The immunological functions of the Appendix: An example of redundancy? |
7 |
| Correlates of GLA family adjuvants' activities |
7 |
| Systems analysis of human vaccine adjuvants |
7 |
| Type III IFNs: Beyond antiviral protection |
7 |
| Asthma from immune pathogenesis to precision medicine |
6 |
